Jacobson Pharma opens books for $100 HK IPO

By Jonathan Breen
08 Sep 2016

Drug company Jacobson Pharma Corp kicked off bookbuilding this week for its potential HK$753m ($97.1m) listing.

BOC International is the sole lead and began taking orders for the IPO on Wednesday morning.

Hong Kong’s largest generic drug company, Jacobson is offering 437.5m primary shares, or 25% of its enlarged share capital, at a range of HK$1.28-HK$1.72 apiece.

The firm could raise between HK$560m and HK$753m ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial